Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

Risk factors of hepatitis B virus surface antigen carriage and serological profile of HBsAg carriers in Lomé Togo, 2016

Authors: Wemboo Afiwa Halatoko, Akouda Patassi, Pauline Yanogo, Leou Ismael Banla, Adjaho Koba, Zoulkaneiri Issa, Koffi Akolly, Agballa Mébiny-Esso Tchalla, Hamadi Assane, Aboukerim Naba-Mouchedou, Bernard Sawadogo, Simon Nouvura Antara, Kossi Badziklou, Abiba Kere Banla, Didier Koumavi Ekouevi, Idrissa Sanou

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

In Togo, the prevalence of Hepatitis B Virus Surface Antigen (HBsAg) among young people aged 15–24 years was estimated at 16.4% in 2010; however, risk factors for HBsAg carriage are poorly documented. We sought to identify risk factors for HBsAg carriage and the serological profile of HBsAg carriers in Lomé (capital city of Togo).

Method

We conducted a case control study from October 2016 to March 2017 in Lomé. Cases and controls were randomly selected from a database of Institut National d’Hygiène (INH) of Lomé during a free screening campaign for hepatitis B. We calculated means, frequencies, proportions, odds ratios (OR), and 95% confidence interval (CI) and performed logistic regression.

Results

We included 83 confirmed cases and 249 controls. The median age was 31 years among cases and 30 years among the controls. The sex ratios (M/F) were 11/6 among cases and 4/3 for the controls. The independent risk factors for HBsAg carriage were the awareness of hepatitis B serological status (OR = 3.56, 95% CI [1.80–7.04]) and Kabyè-tem ethnic group (OR = 3.56, 95% CI [1.98–6.39]). Among HBsAg carriers, 13.3% were at the viral replication stage (all of whom were between 30 and 45 years of age) and 1.2% were at the acute stage of the disease. The prevalence of co-infection with hepatitis B and C was 4.80%. All co-infections were in women aged 24–28 years.

Conclusion

The Kabyè-tem ethnic group is at risk of HBsAg carriage in Lomé. Of note, most HBsAg carriers in this ethnic group are aware of their HBsAg serological status. Furthermore, the prevalence of Hepatitis among adults of reproductive age is high and is cause for concern. We therefore recommend screening and vaccination campaigns at subsidized prices among people aged 30 years and older.
Literature
1.
go back to reference WHO. Guidelines Approved by the Guidelines Review Committee. In: Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015. WHO. Guidelines Approved by the Guidelines Review Committee. In: Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015.
4.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–128.CrossRef Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–128.CrossRef
5.
go back to reference IHME. Global burden of disease and WHO/UNAIDS estimates. In: Global Burden of Disease; 2017. IHME. Global burden of disease and WHO/UNAIDS estimates. In: Global Burden of Disease; 2017.
7.
go back to reference WHO. Weekly epidemiological record. In: World Health Organization, vol. vol. 40; 2009. p. 405–20. WHO. Weekly epidemiological record. In: World Health Organization, vol. vol. 40; 2009. p. 405–20.
8.
go back to reference Chen L, Liu F, Fan X, Gao J, Chen N, Wong T, Wu J, Wen SW. Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues. Int J Infect Dis. 2009;13(1):20–3.CrossRef Chen L, Liu F, Fan X, Gao J, Chen N, Wong T, Wu J, Wen SW. Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues. Int J Infect Dis. 2009;13(1):20–3.CrossRef
9.
go back to reference Banla AKGK, Halatoko WA, Layibo Y, Akolly K, Maman I, Tamekloe TA, Feteke L, Vovor A, Pitche P. Prevalence of the surface antigen of hepatitis B virus among youth aged 15 to 24 in TOGO in 2010. J Infec Dis Ther. 2015;3:1–5.CrossRef Banla AKGK, Halatoko WA, Layibo Y, Akolly K, Maman I, Tamekloe TA, Feteke L, Vovor A, Pitche P. Prevalence of the surface antigen of hepatitis B virus among youth aged 15 to 24 in TOGO in 2010. J Infec Dis Ther. 2015;3:1–5.CrossRef
10.
go back to reference Kolou M, Katawa G, Salou M, Gozo-Akakpo KS, Dossim S, Kwarteng A, Prince-David M. High prevalence of hepatitis B virus infection in the age range of 20-39 years old individuals in Lome. Open Virol J. 2017;11:1–7.CrossRef Kolou M, Katawa G, Salou M, Gozo-Akakpo KS, Dossim S, Kwarteng A, Prince-David M. High prevalence of hepatitis B virus infection in the age range of 20-39 years old individuals in Lome. Open Virol J. 2017;11:1–7.CrossRef
11.
go back to reference Ekouevi D, Thomas A, Sewu D, Lawson-Ananissoh L, Bk T, Salou M, Ketoh G, David M, Coffie P, Redah D. Prevalence of Hepatitis B among Students from the University of Lomé, Togo in 2015, vol. vol. 07; 2017. Ekouevi D, Thomas A, Sewu D, Lawson-Ananissoh L, Bk T, Salou M, Ketoh G, David M, Coffie P, Redah D. Prevalence of Hepatitis B among Students from the University of Lomé, Togo in 2015, vol. vol. 07; 2017.
12.
go back to reference Ministère de la Santé du Togo. Programme Elargi de Vaccination du Togo, Rapport d’activités de l’année 2009. 2010 p. 7 Ministère de la Santé du Togo. Programme Elargi de Vaccination du Togo, Rapport d’activités de l’année 2009. 2010 p. 7
13.
go back to reference Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R: The status of hepatitis B control in the African region. 2017(1937–8688 (Electronic)). Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R: The status of hepatitis B control in the African region. 2017(1937–8688 (Electronic)).
14.
go back to reference Espert L1, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N. SG20, A new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem. 2003;278(18):16151–8. Espert L1, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N. SG20, A new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem. 2003;278(18):16151–8.
15.
go back to reference Hennig BJ, Hall AJ. Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa. Sci Total Environ. 2012;423:202–9.CrossRef Hennig BJ, Hall AJ. Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa. Sci Total Environ. 2012;423:202–9.CrossRef
16.
go back to reference Olalekan A. Prevalence and risk factors for hepatitis B and C among sexually active undergraduates in southwestern Nigeria. Ann Trop Med Public Health. 2015;8(6):235–40.CrossRef Olalekan A. Prevalence and risk factors for hepatitis B and C among sexually active undergraduates in southwestern Nigeria. Ann Trop Med Public Health. 2015;8(6):235–40.CrossRef
17.
go back to reference Ephraim R, Donko I, Sakyi SA, Ampong J, Agbodjakey H. Seroprevalence and risk factors of hepatitis B and hepatitis C infections among pregnant women in the Asante Akim north municipality of the Ashanti region, Ghana; a cross sectional study. Afr Health Sci. 2015;15(3):709–13.CrossRef Ephraim R, Donko I, Sakyi SA, Ampong J, Agbodjakey H. Seroprevalence and risk factors of hepatitis B and hepatitis C infections among pregnant women in the Asante Akim north municipality of the Ashanti region, Ghana; a cross sectional study. Afr Health Sci. 2015;15(3):709–13.CrossRef
18.
go back to reference Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2.CrossRef Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2.CrossRef
19.
go back to reference Patassi A A, Kotosso A, Salou M, Bawe LD, Krivine A, Ephrem M, et al. Prevalence des marqueurs du virus de l’hepatite B chez les patients infectes par le VIH et traites par anti-retroviraux dans un pays a ressources limitees. J Rech Sci Univ Lomé. 2015;17(3):685–92. Patassi A A, Kotosso A, Salou M, Bawe LD, Krivine A, Ephrem M, et al. Prevalence des marqueurs du virus de l’hepatite B chez les patients infectes par le VIH et traites par anti-retroviraux dans un pays a ressources limitees. J Rech Sci Univ Lomé. 2015;17(3):685–92.
20.
go back to reference Nagu TJ, Bakari M, Matee M. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar Es Salaam. Tanzania BMC public health. 2008;8:416.CrossRef Nagu TJ, Bakari M, Matee M. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar Es Salaam. Tanzania BMC public health. 2008;8:416.CrossRef
21.
go back to reference Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, Bessong PO. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon. AIDS Res Ther. 2017;14(1):11.CrossRef Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, Bessong PO. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon. AIDS Res Ther. 2017;14(1):11.CrossRef
22.
go back to reference Hudu SA, Harmal NS, Saeed MI, Alshrari AS, Malik YA, Niazlin MT, Hassan R, Sekawi Z. Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia. Afr Health Sci. 2016;16(3):677–83.CrossRef Hudu SA, Harmal NS, Saeed MI, Alshrari AS, Malik YA, Niazlin MT, Hassan R, Sekawi Z. Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia. Afr Health Sci. 2016;16(3):677–83.CrossRef
Metadata
Title
Risk factors of hepatitis B virus surface antigen carriage and serological profile of HBsAg carriers in Lomé Togo, 2016
Authors
Wemboo Afiwa Halatoko
Akouda Patassi
Pauline Yanogo
Leou Ismael Banla
Adjaho Koba
Zoulkaneiri Issa
Koffi Akolly
Agballa Mébiny-Esso Tchalla
Hamadi Assane
Aboukerim Naba-Mouchedou
Bernard Sawadogo
Simon Nouvura Antara
Kossi Badziklou
Abiba Kere Banla
Didier Koumavi Ekouevi
Idrissa Sanou
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-6320-x

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue